Eaton Vance Management Amphastar Pharmaceuticals, Inc. Transaction History

Eaton Vance Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$22.96 - $36.45 $46,700 - $74,139	-2,034 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$18.14 - $23.29 $8,943 - $11,481	493 Added 31.99%	2,034 $0
Q3 2021 Nov 15, 2021	SELL	$17.83 - $21.49 $90,968 - $109,641	-5,102 Reduced 76.8%	1,541 $0
Q2 2021 Aug 16, 2021	BUY	$17.11 - $20.92 $111,215 - $135,980	6,500 Added 4545.45%	6,643 $134,000
Q1 2021 May 17, 2021	BUY	$17.21 - $20.65 $2,461 - $2,952	143 New	143 $3,000

258

33.8M

20.8K

11.6K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.05B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

Stay updated on Eaton Vance Management with notifications on news.